The GTP Team would like to wish you a very happy and successful 2019! We’d also like to take advantage of this opportunity to quickly look back on 2018 and lift (a bit of) the veil on what you can look forward to in 2019.
GTP is looking for a Business Developer to grow our business and develop our presence and sales in France and Europe.
VRI, ANRS and Novasep have signed an agreement to launch the GMP-compliant manufacturing of two experimental vaccines for the prevention and treatment of HIV-1/AIDS
The GTP team has developed CHO-based transient transfection services using an optimized in-house protocol for timely production of recombinant proteins
Why membrane chromatography may be beneficial to your protein purification process. Why and where you should use membrane chromatography.
Advice from GTP’s experts to help you define and develop the best process for your recombinant protein and antibody project.
What is antibody humanisation and what are the main differences between chimeric, humanised and fully human antibodies? An overview of what we learned from our discussions with Olivier Léger, an expert in antibody engineering with over 25 years' experience in the field.
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety policy.
The design, operation and maintenance procedure for low endotoxin levels, of our well adapted and functional but not state-of-the-art purified water distribution loop.